Tag: Premarket Approval
-
GRAIL’s Galleri Wins FDA Panel Backing for Multi-Cancer Blood Test
FDA advisers backed GRAIL’s Galleri multi-cancer blood test, but a split effectiveness vote leaves key questions ahead of the final PMA decision.
FDA advisers backed GRAIL’s Galleri multi-cancer blood test, but a split effectiveness vote leaves key questions ahead of the final PMA decision.